MedTrace Logo

A Study of Neurofeedback for the Treatment of Parkinson's Disease

NCT03837548 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-09-11

No results posted yet for this study

Summary

This study aims to reveal relationship between brain activities and the symptoms of Parkinson disease when a neurofeedback training was applied for them.

Conditions

  • Parkinson Disease

Interventions

OTHER

Training with Neurofeedback

Neurofeedback the brain activities by Magnetoencephalography

OTHER

The other Training with Neurofeedback

Neurofeedback the brain activities by Magnetoencephalography

Sponsors & Collaborators

  • Japan Agency for Medical Research and Development

    collaborator OTHER_GOV

  • Osaka University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03837548 on ClinicalTrials.gov